Internationale Publikationen
Hier stellen wir eine Auswahl wissenschaftlicher Veröffentlichungen zur Verfügung, die im Zusammenhang mit der IOZK-Immuntherapie stehen.
Sie können mit Hilfe der Filter eine Auswahl nach Tumorarten und Methoden treffen, oder Suchbegriffe eingeben.
Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination (DCVax-L) in glioblastoma: breakthrough or fata morgana?
/in Dendritic Cells, Glioblastoma, International Publications /von 2022-12-23 / Neuro Oncol 2022 Dec;Derivation and external validation of dendritic cell-related gene signatures for predicting prognosis and immunotherapy efficacy in bladder urothelial carcinoma
/in Checkpoint-Inhibitors, Dendritic Cells, International Publications, Urothelial Carcinoma /von 2022-12-12 / Front Immunol 2022;13:1080947Dendritic cell vaccines improve the glioma microenvironment: Influence, challenges, and future directions
/in Dendritic Cells, Glioblastoma, International Publications /von 2022-12-04 / Cancer Med 2023 Mar;12(6):7207-7221Immunotherapy for the treatment of pediatric brain tumors: a narrative review
/in Brain Tumors in Children, Dendritic Cells, International Publications, Newcastle Disease Virus /von 2022-12-01 / Transl Pediatr 2022 Dec;11(12):2040-2056Oncolytic Viruses for the Treatment of Bladder Cancer: Advances, Challenges, and Prospects
/in International Publications, Newcastle Disease Virus /von 2022-11-26 / J Clin Med 2022 Nov;11(23)Counteracting Immunosuppression in the Tumor Microenvironment by Oncolytic Newcastle Disease Virus and Cellular Immunotherapy
/in International Publications, IOZK Veröffentlichungen /von 2022-10-27 / Int J Mol Sci 2022 Oct;23(21)Commentary on „Systematic review about complementary medical hyperthermia in oncology“ by Liebl et al
/in Hyperthermia, International Publications /von 2022-10-14 / Clin Exp Med 2022 Nov;22(4):667-672Cellular Immunotherapy for Medulloblastoma
/in Brain Tumors in Children, Dendritic Cells, International Publications /von 2022-10-11 / Neuro Oncol 2022 Oct;Immunogenic Cell Death Role in Urothelial Cancer Therapy
/in Immunogenic Cell Death, International Publications, Newcastle Disease Virus, Urothelial Carcinoma /von 2022-09-18 / Curr Oncol 2022 Sep;29(9):6700-67133-Dimensional coculture of breast cancer cell lines with adipose tissue-Derived stem cells reveals the efficiency of oncolytic Newcastle disease virus infection labeling technology
/in Breast Cancer, International Publications, Newcastle Disease Virus /von 2022-09-12 / Front Mol Biosci 2022;9:754100A Phase I-II multicenter trial with Avelumab plus autologous dendritic cell vaccine in pre-treated mismatch repair-proficient (MSS) metastatic colorectal cancer patients; GEMCAD 1602 study
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2022-09-09 / Cancer Immunol Immunother 2023 Apr;72(4):827-840Dendritic-Cell-Vaccine-Based Immunotherapy for Hepatocellular Carcinoma: Clinical Trials and Recent Preclinical Studies
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2022-09-08 / Cancers (Basel) 2022 Sep;14(18)Current and emerging immunotherapeutic approaches for biliary tract cancers
/in Dendritic Cells, Gallbladder Cancer, International Publications /von 2022-09-07 / Hepatobiliary Pancreat Dis Int 2022 Oct;21(5):440-449Oncolytic Newcastle Disease Virus Co-Delivered with Modified PLGA Nanoparticles Encapsulating Temozolomide against Glioblastoma Cells: Developing an Effective Treatment Strategy
/in Glioblastoma, International Publications, Newcastle Disease Virus /von 2022-09-06 / Molecules 2022 Sep;27(18)Immunogenic Cell Death Enhances Immunotherapy of Diffuse Intrinsic Pontine Glioma: From Preclinical to Clinical Studies
/in Brain Tumors in Children, Dendritic Cells, Immunogenic Cell Death, International Publications, Newcastle Disease Virus /von 2022-08-24 / Pharmaceutics 2022 Aug;14(9)Dendritic Cell Vaccines: A Promising Approach in the Fight against Ovarian Cancer
/in Dendritic Cells, International Publications, Ovarian Cancer /von 2022-08-21 / Cancers (Basel) 2022 Aug;14(16)Dendritic Cell-Based Vaccines Against Cancer: Challenges, Advances and Future Opportunities
/in Dendritic Cells, International Publications /von 2022-08-10 / Immunol Invest 2022 Nov;51(8):2133-2158Breast cancer vaccines: New insights into immunomodulatory and nano-therapeutic approaches
/in Breast Cancer, Dendritic Cells, International Publications /von 2022-08-03 / J Control Release 2022 Sep;349:844-875Triiodothyronine-stimulated dendritic cell vaccination boosts antitumor immunity against murine colon cancer
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2022-08-01 / Int Immunopharmacol 2022 Sep;110:109016Leveraging epigenetics to enhance the efficacy of cancer-testis antigen: a potential candidate for immunotherapy
/in Dendritic Cells, International Publications, Ovarian Cancer /von 2022-07-25 / Epigenomics 2022 Jul;14(14):865-886